384 related articles for article (PubMed ID: 8383288)
41. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
Yano K; Saji M; Hidaka A; Moriya N; Okuno A; Kohn LD; Cutler GB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1162-8. PubMed ID: 7714085
[TBL] [Abstract][Full Text] [Related]
42. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells.
Gudermann T; Birnbaumer M; Birnbaumer L
J Biol Chem; 1992 Mar; 267(7):4479-88. PubMed ID: 1311310
[TBL] [Abstract][Full Text] [Related]
43. Cloning and functional expression of the equine luteinizing hormone/chorionic gonadotrophin receptor.
Saint-Dizier M; Foulon-Gauze F; Lecompte F; Combarnous Y; Chopineau M
J Endocrinol; 2004 Dec; 183(3):551-9. PubMed ID: 15590981
[TBL] [Abstract][Full Text] [Related]
44. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor.
Abell A; Liu X; Segaloff DL
J Biol Chem; 1996 Feb; 271(8):4518-27. PubMed ID: 8626807
[TBL] [Abstract][Full Text] [Related]
45. Luteinizing hormone receptors are self-associated in slowly diffusing complexes during receptor desensitization.
Horvat RD; Barisas BG; Roess DA
Mol Endocrinol; 2001 Apr; 15(4):534-42. PubMed ID: 11266505
[TBL] [Abstract][Full Text] [Related]
46. A functional determinant in human luteinizing hormone and chorionic gonadotropin: differential effect of mutations about beta-GLN-54.
Hu SB; Johnson L; Roche PC; Keutmann HT
Endocrinology; 1997 Apr; 138(4):1627-33. PubMed ID: 9075724
[TBL] [Abstract][Full Text] [Related]
47. Treatment of human endometrial gland epithelial cells with chorionic gonadotropin/luteinizing hormone increases the expression of the cyclooxygenase-2 gene.
Zhou XL; Lei ZM; Rao CV
J Clin Endocrinol Metab; 1999 Sep; 84(9):3364-77. PubMed ID: 10487712
[TBL] [Abstract][Full Text] [Related]
48. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action.
Müller T; Gromoll J; Simoni M
J Clin Endocrinol Metab; 2003 May; 88(5):2242-9. PubMed ID: 12727981
[TBL] [Abstract][Full Text] [Related]
49. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
Latronico AC; Shinozaki H; Guerra G; Pereira MA; Lemos Marini SH; Baptista MT; Arnhold IJ; Fanelli F; Mendonca BB; Segaloff DL
J Clin Endocrinol Metab; 2000 Dec; 85(12):4799-805. PubMed ID: 11134146
[TBL] [Abstract][Full Text] [Related]
50. Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA.
Hipkin RW; Sánchez-Yagüe J; Ascoli M
Mol Endocrinol; 1992 Dec; 6(12):2210-8. PubMed ID: 1491699
[TBL] [Abstract][Full Text] [Related]
51. Identification of hormone-binding regions of the luteinizing hormone/human chorionic gonadotropin receptor using synthetic peptides.
Roche PC; Ryan RJ; McCormick DJ
Endocrinology; 1992 Jul; 131(1):268-74. PubMed ID: 1612004
[TBL] [Abstract][Full Text] [Related]
52. [The human chorionic gonadotropin (hCG) receptor: a new class within the family of GTP protein coupled receptors. Epitope mapping of receptor-bound agonistic and antagonistic forms of hCG].
Schwarz S; Krude H
Wien Klin Wochenschr; 1992; 104(13):369-90. PubMed ID: 1636261
[TBL] [Abstract][Full Text] [Related]
53. Luteinizing hormone and human chorionic gonadotropin: origins of difference.
Choi J; Smitz J
Mol Cell Endocrinol; 2014 Mar; 383(1-2):203-13. PubMed ID: 24365330
[TBL] [Abstract][Full Text] [Related]
54. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding.
Thomas D; Rozell TG; Liu X; Segaloff DL
Mol Endocrinol; 1996 Jun; 10(6):760-8. PubMed ID: 8776736
[TBL] [Abstract][Full Text] [Related]
55. The lutropin/choriogonadotropin receptor is palmitoylated at intracellular cysteine residues.
Zhu H; Wang H; Ascoli M
Mol Endocrinol; 1995 Feb; 9(2):141-50. PubMed ID: 7776964
[TBL] [Abstract][Full Text] [Related]
56. Co-evolution of ligand-receptor pairs.
Moyle WR; Campbell RK; Myers RV; Bernard MP; Han Y; Wang X
Nature; 1994 Mar; 368(6468):251-5. PubMed ID: 8145825
[TBL] [Abstract][Full Text] [Related]
57. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone.
Wang Z; Liu X; Ascoli M
Mol Endocrinol; 1997 Feb; 11(2):183-92. PubMed ID: 9013765
[TBL] [Abstract][Full Text] [Related]
58. hCG-receptor binding and transmembrane signaling.
Puett D; Bhowmick N; Fernandez LM; Huang J; Wu C; Narayan P
Mol Cell Endocrinol; 1996 Dec; 125(1-2):55-64. PubMed ID: 9027343
[TBL] [Abstract][Full Text] [Related]
59. Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production.
Ji I; Ji TH
J Biol Chem; 1991 Aug; 266(23):14953-7. PubMed ID: 1714448
[TBL] [Abstract][Full Text] [Related]
60. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor.
Latronico AC; Chai Y; Arnhold IJ; Liu X; Mendonca BB; Segaloff DL
Mol Endocrinol; 1998 Mar; 12(3):442-50. PubMed ID: 9514160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
